Yang Jin-Yi, Wei Wei, Lan Yu-Long, Liu Jun-Qiang, Wang Hai-Bo, Li Shao
Department of Urology, Dalian Friendship Hospital, Liaoning 116001, China.
Department of Physiology, Dalian Medical University, Dalian, 116044, China.
Urol J. 2015 Dec 23;12(6):2417-21.
To evaluate the clinical efficacy of bladder hydrodistention and intravesical sodium hyaluronate in the treatment of interstitial cystitis (IC).
Twenty-one patients with IC received intravesical sodium hyaluronate therapy under nerve block or intravenous anesthesia. Bladders were perfused with 100 cmH2O perfusion pressure and expanded for 10 min and were later injected with 40 mg/50 mL sodium hyaluronate through the catheter. After 1 h, the perfusion fluid was released. Perfusion was applied once per week, 4 to 6 times as a course of treatment.
Under anesthesia, the average bladder capacity was 191.62 ± 88.67 mL, and after bladder expansion, the bladder capacity reached 425.33 ± 79.83 mL (P = .000). There were 2 suspected bladder ruptures after bladder expansion at 6.5 min and 7.2 min. After 10 min of bladder expansion, there were 19 cases of significantly gross hematuria. After treatment, the catheters of 17 patients were removed at 24 h; for the 2 cases of hematuria, catheters were removed at 72 h and for the 2 cases of suspected bladder rupture, catheters were removed after 4 days. After catheter removal, the pain threshold significantly decreased, and the maximum urinary output increased slightly. Compared with values before treatment, the day before the second injection of sodium hyaluronate, the frequency of urination decreased significantly (32.8 vs. 18.5 times/24 h), the maximum urinary output increased significantly (86.7 vs. 151.9 mL), the pain decreased significantly (8.7 vs. 3.0), and the O'Leary-Sant IC score and quality of life score were significantly decreased (30.0 vs. 17.0 and 5.9 vs. 2.4, respectively) (P = .000).
Bladder hydrodistention under anesthesia for patients with severe intractable IC produces immediate effectiveness; sodium hyaluronic infusion can alleviate frequent urination and pain, and the efficacy was positively correlated with the duration of treatment.
评估膀胱水扩张联合膀胱内注射透明质酸钠治疗间质性膀胱炎(IC)的临床疗效。
21例IC患者在神经阻滞或静脉麻醉下接受膀胱内透明质酸钠治疗。膀胱以100 cmH₂O的灌注压力灌注并扩张10分钟,随后通过导管注入40 mg/50 mL透明质酸钠。1小时后,放出灌注液。每周灌注1次,4至6次为一个疗程。
麻醉下平均膀胱容量为191.62±88.67 mL,膀胱扩张后膀胱容量达到425.33±79.83 mL(P = .000)。膀胱扩张后6.5分钟和7.2分钟时有2例疑似膀胱破裂。膀胱扩张10分钟后,有19例出现明显肉眼血尿。治疗后,17例患者的导管在24小时拔除;2例血尿患者的导管在72小时拔除,2例疑似膀胱破裂患者的导管在4天后拔除。拔除导管后,疼痛阈值显著降低,最大尿量略有增加。与治疗前相比,在第二次注射透明质酸钠的前一天,排尿频率显著降低(32.8次/24小时对18.5次/24小时),最大尿量显著增加(86.7 mL对151.9 mL),疼痛显著减轻(8.7对3.0),O'Leary-Sant IC评分和生活质量评分显著降低(分别为30.0对17.0和5.9对2.4)(P = .000)。
麻醉下对重度难治性IC患者进行膀胱水扩张可立即产生疗效;透明质酸钠灌注可缓解尿频和疼痛,疗效与治疗持续时间呈正相关。